The Surveillance Clinical Study of Rickettsiosis
The Surveillance (Non-interventional, Observational) Multicenter Clinical Study of Rickettsiosis
1 other identifier
observational
2,000
1 country
24
Brief Summary
The purpose of this surveillance (non-interventional) clinical study is to genotype the causative agents of rickettsioses in biological samples of patients from the regions of Russia. This is a solely observational study in the patients with diagnosed or suspected tick-borne rickettsioses, with no intervention to the routine treatment and diagnostic process. During the study the medical history, diseases progress and symptoms, as well as treatments are being registered in individual case report forms. The rests of the samples used for standard diagnostics (blood, plasma, buffy coat, or serum, and/or swab of the eschar) are being collected and afterwards analyzed for rickettsial genotypes. These data are being compared to the medical history and symptoms of the patients in order to identify clinical patterns specific for causative agents of rickettsioses. Informed consent from all patients or their legal representatives are being collecting. The study was approved by the ethical committee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Typical duration for all trials
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 28, 2023
CompletedFirst Posted
Study publicly available on registry
December 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 19, 2026
February 1, 2026
3.8 years
November 28, 2023
February 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Genetic identification of the rickettsia species
Genetic identification of the rickettsia species causing rickettsioses, including new circulating genotypes
up to 4 weeks
Eligibility Criteria
Male and female patients of any age with diagnosed or suspected tick-born rickettsioses.
You may qualify if:
- To be included in the study, the subject must meet all the following criteria:
- Written informed consent by the subject (or their legal representative) to participate in the study;
- Men and women of any age, including children, who:
- have sought medical care (outpatient or inpatient) with suspected or diagnosed rickettsiosis; or have sought medical care (inpatient) with a history of tick bites and elevated body temperature (at least 37.2 °C lasting at least 48 hours).
You may not qualify if:
- \- Inability or unwillingness of the subject (or their legal representative) to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (24)
Chemal District Hospital
Chemal, Altai Republic, 649240, Russia
Center for AIDS Prophylaxis and Treatment
Gorno-Altaysk, Altai Republic, 649002, Russia
Choya District Hospital
Gusevka, Altai Republic, 649180, Russia
Kosh-Agach District Hospital
Kosh-Agach, Altai Republic, 649780, Russia
Mayma District Hospital
Mayma, Altai Republic, 649100, Russia
Onguday District Hospital
Onguday, Altai Republic, 649440, Russia
Ust-Kan District Hospital
Ust'-Kan, Altai Republic, 649450, Russia
Ust-Koksa District Hospital
Ust'-Koksa, Altai Republic, 649490, Russia
Ulagan District Hospital
Ust'-Ulagan, Altai Republic, 649750, Russia
Altai State Medical University
Barnaul, Altayskiy Kray, 656038, Russia
City Hospital No. 5
Barnaul, Altayskiy Kray, 656045, Russia
Barnaul Regional Clinical Hospital for Emergency Medical Care No. 2
Barnaul, Altayskiy Kray, 656050, Russia
Biysk Central City Hospital
Biysk, Altayskiy Kray, 659323, Russia
Regional Infectious Diseases Clinical Hospital named after A.M. Nichoga
Astrakhan, Astrakhan Oblast, 414004, Russia
Irkutsk State Medical University
Irkutsk, Irkutsk Oblast, 664003, Russia
Irkutsk Regional Infectious Diseases Clinical Hospital
Irkutsk, Irkutsk Oblast, 664043, Russia
City Clinical Hospital named after Professor A.M. Voyno-Yasenetsky
Khabarovsk, Khabarovskiy Kray, 680035, Russia
Imeni Lazo District Hospital
Pereyaslavka, Khabarovskiy Kray, 682910, Russia
Pskov Regional Infectious Diseases Clinical Hospital
Pskov, Pskov Oblast, 180016, Russia
Republican Clinical Infectious Diseases Hospital
Abakan, Respublika Khakasiya, 655009, Russia
Abakan Interdistrict Clinical Hospital
Abakan, Respublika Khakasiya, 655017, Russia
Sayanogorsk Interdistrict Hospital
Sayanogorsk, Respublika Khakasiya, 655602, Russia
Infectious Diseases Hospital
Kyzyl, Respublika Tyva, 667003, Russia
Yakutia Republican Clinical Hospital
Yakutsk, Sakha, 677005, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexey V. Kostarnoy, PhD
Gamaleya Research Center of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2023
First Posted
December 8, 2023
Study Start
April 1, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share